Sort by
Refine Your Search
-
Category
-
Field
-
experience) is available in the Cellular Therapy Production Center (CTPC). This is a fast-paced lab involved in cutting edge technology, research and clinical immunotherapeutic programs. New personnel will
-
. Human synthetic insulin, monoclonal antibodies and numerous breakthrough cancer drugs are based on technology developed at the institution. AccessHope™, a subsidiary launched in 2019 serves employers and
-
information on Dr. Schones’ research please visit here . · PhD or M.D. in biology, computer science, biomedical engineering, physics or other related discipline. · Excellent communication and
-
Knowledge of collection agency work, probate courts and its requirements, and bankruptcy laws and regulations Advanced written and verbal communication skills Proficient with technology, spreadsheet
-
its requirements, and bankruptcy laws and regulations Advanced written and verbal communication skills Proficient with technology, spreadsheet management skills, with the ability to analyze trends
-
synthetic insulin, monoclonal antibodies and numerous breakthrough cancer drugs are based on technology developed at the institution. AccessHope™, a subsidiary launched in 2019 serves employers and their
-
values and goals, advance care planning, and leveraging technology to enhance the coordination and delivery of patient-centered medical care in serious illness. As a successful candidate, you will
-
-paced research in cutting-edge technology, immunotherapeutic programs, and a commitment to delivering innovative solutions to critical illnesses. For more information on T Cell Therapeutics research
-
leukemogenesis as well as disease relapse in order to design novel inhibitors to intervene the malignancies · Collaborative analyses of myeloid cancers genomics using high-throughput single-cell technology
-
immune checkpoints and ligands on various hematopoietic malignant and solider tumor cells with high-throughput screening and protein engineering approaches developed in the lab, and develop novel cancer